
KLOW 80mg (Pen)
80 mg
$349.99 CAD

GLP-1 receptor agonist · Research reagent
Targets the GLP-1 receptor. Clinical research examines blood-sugar control and body weight, alongside questions about appetite and insulin signalling.
$58.99 CAD
· $11.80 / mgVial discount: 5% off at 3, 10% at 5, 20% at 10 eligible single vials, any mix. Applied automatically in the cart.
Interac e-Transfer
$9.99 shipping, free from $250 · Ships from Canada · Canada only
Shipping and returns: Ships next business day from Canada · $9.99 shipping, free from $250 · Arrives right or we make it right
For research use only. Not for human consumption.
Lab report available on request.
Semaglutide 5mg is catalogued here as: GLP-1 receptor agonist. Studied in adults for body-weight and glucose-related outcomes; appetite signalling and blood-glucose actions are distinct mechanisms. Semaglutide is a GLP-1 receptor agonist. In plain terms, official labelling describes it acting on two fronts that are worth keeping apart: appetite and calorie intake on one side, and blood-glucose regulation on the other. This listing is laboratory research material, it is not Ozempic, not Wegovy and not an authorized medicine. Targets the GLP-1 receptor. Clinical research examines blood-sugar control and body weight, alongside questions about appetite and insulin signalling.
Mechanism statements come from regulated product labelling; outcome statements come from randomized trials that specify population, comparator, endpoint and duration, and that report adverse effects alongside benefits.
Official labelling describes two separate things. For appetite, it states that GLP-1 regulates appetite and calorie intake, that GLP-1 receptors are present in brain regions involved in appetite regulation, and that semaglutide decreases calorie intake likely through an effect on appetite. For blood glucose, it separately describes glucose-dependent insulin secretion and reduced glucagon secretion, which lower blood glucose, and describes delayed gastric emptying as a further separate effect. A 2021 trial in 1,961 adults with overweight or obesity without diabetes, over 68 weeks with a lifestyle intervention, reported body-weight reduction and gastrointestinal adverse effects.
Official US label literature: Labelling separates appetite and calorie-intake regulation from glucose-dependent insulin secretion and reduced glucagon secretion. The label describes a regulated medicine, not this catalogue material or Canadian authorization.
Bloom Labs lists Semaglutide 5mg as a vial in 5 mg. Prices are shown in Canadian dollars, and orders ship from Canada by tracked Canadian service.
A lab report for Semaglutide 5mg is available on request. Bloom Labs does not display a report until it is matched to the exact compound and strength.
Shipped lyophilized (freeze-dried) and stable at room temperature in transit. Store sealed vials in the fridge or freezer on arrival. Once reconstituted, refrigerate. Anything not right? Our guarantee covers it.

80 mg
$349.99 CAD

20 mg
$299.99 CAD

40 mg
$299.99 CAD